{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:09:56Z","timestamp":1793956196107,"version":"4.8.0"},"reference-count":147,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T00:00:00Z","timestamp":1585785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501539"],"award-info":[{"award-number":["81501539"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81320108015"],"award-info":[{"award-number":["81320108015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2016A030312008"],"award-info":[{"award-number":["2016A030312008"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"DOI":"10.3389\/fcell.2020.00160","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T04:56:31Z","timestamp":1585803391000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":72,"title":["Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets"],"prefix":"10.3389","volume":"8","author":[{"given":"Can-Bin","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Tao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.exphem.2015.08.013","article-title":"FANCA safeguards interphase and mitosis during hematopoiesis in vivo.","volume":"43","author":"Abdul-Sater","year":"2015","journal-title":"Exp. Hematol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-cancer risk in families with mutations in PALB2.","volume":"371","author":"Antoniou","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gepi.1014","article-title":"Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.","volume":"21","author":"Antoniou","year":"2001","journal-title":"Genet. Epidemiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2147\/BCTT.S111394","article-title":"Current perspectives on CHEK2 mutations in breast cancer.","volume":"9","author":"Apostolou","year":"2017","journal-title":"Breast Cancer (Dove Med. Press)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41571-018-0055-6","article-title":"Synthetic lethal therapies for cancer: what\u2019s next after PARP inhibitors?","volume":"15","author":"Ashworth","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mrfmmm.2009.01.013","article-title":"Fanconi anemia and its diagnosis.","volume":"668","author":"Auerbach","year":"2009","journal-title":"Mutat. Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/humu.22206","article-title":"Analysis of the novel fanconi anemia gene SLX4\/FANCP in familial breast cancer cases.","volume":"34","author":"Bakker","year":"2013","journal-title":"Hum. Mutat."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1093\/carcin\/bgl062","article-title":"FANCD2 associated with sporadic breast cancer risk.","volume":"27","author":"Barroso","year":"2006","journal-title":"Carcinogenesis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/BCTT.S145826","article-title":"Complexes formed by mutant p53 and their roles in breast cancer.","volume":"10","author":"Bellazzo","year":"2018","journal-title":"Breast Cancer (Dove Med. Press)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"9591","DOI":"10.1158\/0008-5472.can-07-1501","article-title":"Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer.","volume":"67","author":"Berwick","year":"2007","journal-title":"Cancer Res."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-017-0195-9","article-title":"DNA damage response and cancer therapeutics through the lens of the Fanconi Anemia DNA repair pathway.","volume":"15","author":"Bhattacharjee","year":"2017","journal-title":"Cell Commun. Signal."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1093\/hmg\/dds013","article-title":"The DNA translocase activity of FANCM protects stalled replication forks.","volume":"21","author":"Blackford","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067538","article-title":"Analysis of PALB2 gene in BRCA1\/BRCA2 negative Spanish hereditary breast\/ovarian cancer families with pancreatic cancer cases.","volume":"8","author":"Blanco","year":"2013","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1042\/bst0340633","article-title":"Cellular functions of the BRCA tumour-suppressor proteins.","volume":"34","author":"Boulton","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"B15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10549-017-4325-2","article-title":"Family history and risk of breast cancer: an analysis accounting for family structure.","volume":"165","author":"Brewer","year":"2017","journal-title":"Breast Cancer Res. Treat"},{"key":"B16","doi-asserted-by":"publisher","first-page":"7701","DOI":"10.1074\/jbc.M111.327296","article-title":"Characterization of BRCA1 protein targeting, dynamics, and function at the centrosome: a role for the nuclear export signal, CRM1, and Aurora A kinase.","volume":"287","author":"Brodie","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.yexcr.2012.11.013","article-title":"The role of BRCA1 in DNA double-strand repair: past and present.","volume":"319","author":"Caestecker","year":"2013","journal-title":"Exp. Cell Res."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2019.102664","article-title":"XRCC1 protein; Form and function.","volume":"81","author":"Caldecott","year":"2019","journal-title":"DNA Repair (Amst.)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3978\/j.issn.2224-4336.2014.07.05","article-title":"Fanconi anemia pathway defects in inherited and sporadic cancers.","volume":"3","author":"Chen","year":"2014","journal-title":"Transl. Pediatr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1200\/jco.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance.","volume":"25","author":"Chen","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1158\/1535-7163.mct-05-0493","article-title":"Chemosensitization to cisplatin by inhibitors of the Fanconi anemia\/BRCA pathway.","volume":"5","author":"Chirnomas","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ng1297-423","article-title":"Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation.","volume":"17","author":"Connor","year":"1997","journal-title":"Nat. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-1-4614-5037-5_9","article-title":"Roles of DNA helicases in the mediation and regulation of homologous recombination.","volume":"767","author":"Daley","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10549-015-3625-7","article-title":"Mutation analysis of PALB2 gene in French breast cancer families.","volume":"154","author":"Damiola","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"B25","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMra0809889","article-title":"Susceptibility pathways in Fanconi\u2019s anemia and breast cancer.","volume":"362","author":"D\u2019Andrea","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nrc970","article-title":"The Fanconi anaemia\/BRCA pathway.","volume":"3","author":"D\u2019Andrea","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/s1097-2765(01)00175-7","article-title":"Role of BRCA2 in control of the RAD51 recombination and DNA repair protein.","volume":"7","author":"Davies","year":"2001","journal-title":"Mol. Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1056\/nejmcpc059002","article-title":"Case records of the Massachusetts general hospital. Weekly clinicopathological exercises. Case 7-2005. A 59-year-old woman with an incidentally discovered adrenal nodule.","volume":"352","author":"Dluhy","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1158\/2159-8290.CD-12-0421","article-title":"Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer.","volume":"3","author":"Domchek","year":"2013","journal-title":"Cancer Discov."},{"key":"B30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/s1535-6108(02)00041-7","article-title":"The BRCA1 suppressor hypothesis: an explanation for the tissue-specific tumor development in BRCA1 patients.","volume":"1","author":"Elledge","year":"2002","journal-title":"Cancer Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nrc2054","article-title":"Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.","volume":"7","author":"Fackenthal","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1038\/onc.2017.46","article-title":"Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.","volume":"36","author":"Foo","year":"2017","journal-title":"Oncogene"},{"key":"B33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nature08136","article-title":"A mechanism linking extra centrosomes to chromosomal instability.","volume":"460","author":"Ganem","year":"2009","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"16107","DOI":"10.1073\/pnas.0804777105","article-title":"Remodeling of DNA replication structures by the branch point translocase FANCM.","volume":"105","author":"Gari","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B35","doi-asserted-by":"publisher","first-page":"5864","DOI":"10.1038\/sj.onc.1209874","article-title":"The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability.","volume":"25","author":"Gudmundsdottir","year":"2006","journal-title":"Oncogene"},{"key":"B36","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10038-008-0285-z","article-title":"Mutational analysis of the breast cancer susceptibility gene BRIP1\/BACH1\/FANCJ in high-risk non-BRCA1\/BRCA2 breast cancer families.","volume":"53","author":"Guenard","year":"2008","journal-title":"J. Hum. Genet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1126\/science.2270482","article-title":"Linkage of early-onset familial breast cancer to chromosome 17q21.","volume":"250","author":"Hall","year":"1990","journal-title":"Science"},{"key":"B38","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.dnarep.2010.01.005","article-title":"FANCJ: solving problems in DNA replication.","volume":"9","author":"Hiom","year":"2010","journal-title":"DNA Repair (Amst.)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1158\/1541-7786.MCR-18-0138","article-title":"PARP1 Trapping by PARP inhibitors drives cytotoxicity in both cancer cells and healthy bone marrow.","volume":"17","author":"Hopkins","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1126\/science.1073834","article-title":"Biallelic inactivation of BRCA2 in Fanconi anemia.","volume":"297","author":"Howlett","year":"2002","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.mrfmmm.2017.05.003","article-title":"Activation of the FA pathway mediated by phosphorylation and ubiquitination.","author":"Ishiai","year":"2017","journal-title":"Mutat. Res."},{"key":"B42","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/35076590","article-title":"The emerging genetic and molecular basis of Fanconi anaemia.","volume":"2","author":"Joenje","year":"2001","journal-title":"Nat. Rev. Genet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1586\/14737159.4.3.393","article-title":"Clinical features of Bloom syndrome and function of the causative gene, BLM helicase.","volume":"4","author":"Kaneko","year":"2004","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8040435","article-title":"PARP inhibitors as a therapeutic agent for homologous recombination deficiency in breast cancers.","volume":"8","author":"Keung","year":"2019","journal-title":"J. Clin. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"15172","DOI":"10.1073\/pnas.1407909111","article-title":"Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer.","volume":"111","author":"Kiiski","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1101\/gad.195248.112","article-title":"Regulation of DNA cross-link repair by the Fanconi anemia\/BRCA pathway.","volume":"26","author":"Kim","year":"2012","journal-title":"Genes Dev."},{"key":"B47","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/1873-3468.12060","article-title":"The role of USP1 autocleavage in DNA interstrand crosslink repair.","volume":"590","author":"Kim","year":"2016","journal-title":"FEBS Lett."},{"key":"B48","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/ng.750","article-title":"Mutations of the SLX4 gene in Fanconi anemia.","volume":"43","author":"Kim","year":"2011","journal-title":"Nat. Genet."},{"key":"B49","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.","volume":"302","year":"2003","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","first-page":"21312","DOI":"10.1074\/jbc.m603290200","article-title":"Functional interplay between BRCA2\/FancD1 and FancC in DNA repair.","volume":"281","author":"Kitao","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1172\/JCI92069","article-title":"Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia.","volume":"127","author":"Knies","year":"2017","journal-title":"J. Clin. Investigat."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.3892\/mmr.2018.9163","article-title":"Fanconi anemia complementation group C protection against oxidative stressinduced betacell apoptosis.","volume":"18","author":"Kulanuwat","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1158\/1078-0432.CCR-11-2821","article-title":"A phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomas.","volume":"18","author":"Kummar","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s10549-011-1681-1","article-title":"Mutation analysis of the SLX4\/FANCP gene in hereditary breast cancer.","volume":"130","author":"Landwehr","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"B55","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1126\/science.1216338","article-title":"Structural basis for DNA damage-dependent poly(ADP-ribosyl)ation by human PARP-1.","volume":"336","author":"Langelier","year":"2012","journal-title":"Science"},{"key":"B56","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/GCO.0b013e3282f42237","article-title":"Promotion of BRCA1-associated triple-negative breast cancer by ovarian hormones.","volume":"20","author":"Lee","year":"2008","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1182\/blood-2003-08-2915","article-title":"Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes.","volume":"103","author":"Levitus","year":"2004","journal-title":"Blood"},{"key":"B58","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ng1625","article-title":"The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J.","volume":"37","author":"Levitus","year":"2005","journal-title":"Nat. Genet."},{"key":"B59","doi-asserted-by":"crossref","first-page":"R1005","DOI":"10.1186\/bcr1336","article-title":"Mutation analysis of FANCD2, BRIP1\/BACH1, LMO4 and SFN in familial breast cancer.","volume":"7","author":"Lewis","year":"2005","journal-title":"Breast Cancer Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0092-8674(81)90015-5","article-title":"Feedback control of mitosis in budding yeast.","volume":"66","author":"Li","year":"1991","journal-title":"Cell"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-015-0182-9","article-title":"PALB2 mutations in breast cancer patients from a multi-ethnic region in northwest China.","volume":"20","author":"Li","year":"2015","journal-title":"Eur. J. Med. Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1056\/NEJMoa1802905","article-title":"Talazoparib in patients with advanced breast cancer and a germline BRCA mutation.","volume":"379","author":"Litton","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nrm3888","article-title":"Signalling dynamics in the spindle checkpoint response.","volume":"15","author":"London","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nrc.2015.21","article-title":"BRCAness revisited.","volume":"16","author":"Lord","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: synthetic lethality in the clinic.","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"key":"B66","doi-asserted-by":"publisher","first-page":"5741","DOI":"10.1002\/jcp.27464","article-title":"Hereditary breast cancer; genetic penetrance and current status with BRCA.","volume":"234","author":"Mahdavi","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00766-9","article-title":"Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility.","volume":"7","author":"Mantere","year":"2017","journal-title":"Sci. Rep."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1056\/NEJMoa1506859","article-title":"DNA-repair defects and olaparib in metastatic prostate cancer.","volume":"373","author":"Mateo","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/ng.569","article-title":"Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.","volume":"42","author":"Meindl","year":"2010","journal-title":"Nat. Genet."},{"key":"B70","doi-asserted-by":"publisher","first-page":"909","DOI":"10.15252\/embj.201693860","article-title":"Interplay between Fanconi anemia and homologous recombination pathways in genome integrity.","volume":"35","author":"Michl","year":"2016","journal-title":"EMBO J."},{"key":"B71","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1182\/blood-2003-11-3997","article-title":"Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin.","volume":"105","author":"Montes de Oca","year":"2005","journal-title":"Blood"},{"key":"B73","first-page":"4842","article-title":"Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation.","volume":"61","author":"Moynahan","year":"2001","journal-title":"Cancer Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1158\/1078-0432.CCR-09-2758","article-title":"Development of a functional assay for homologous recombination status in primary cultures of epithelial ovarian tumor and correlation with sensitivity to poly(ADP-ribose) polymerase inhibitors.","volume":"16","author":"Mukhopadhyay","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1158\/0008-5472.CAN-12-2753","article-title":"Trapping of PARP1 and PARP2 by clinical PARP inhibitors.","volume":"72","author":"Murai","year":"2012","journal-title":"Cancer Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1158\/1535-7163.MCT-13-0803","article-title":"Stereospecific PARP trapping by BMN 673 and comparison with olaparib and rucaparib.","volume":"13","author":"Murai","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"B77","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrm2163","article-title":"The spindle-assembly checkpoint in space and time.","volume":"8","author":"Musacchio","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s10147-015-0906-4","article-title":"Analysis of PALB2 mutations in 155 Japanese patients with breast and\/or ovarian cancer.","volume":"21","author":"Nakagomi","year":"2016","journal-title":"Int. J. Clin. Oncol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrc.2017.116","article-title":"Fanconi anaemia and cancer: an intricate relationship.","volume":"18","author":"Nalepa","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"B80","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1172\/JCI67364","article-title":"Fanconi anemia signaling network regulates the spindle assembly checkpoint.","volume":"123","author":"Nalepa","year":"2013","journal-title":"J. Clin. Invest."},{"key":"B81","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1128\/mcb.12.9.3857","article-title":"A delay in the Saccharomyces cerevisiae cell cycle that is induced by a dicentric chromosome and dependent upon mitotic checkpoints.","volume":"12","author":"Neff","year":"1992","journal-title":"Mol. Cell. Biol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jamaoncol.2016.5592","article-title":"Association between loss-of-function mutations within the FANCM gene and early-onset familial breast cancer.","volume":"3","author":"Neidhardt","year":"2017","journal-title":"JAMA Oncol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1667\/RR1290.1","article-title":"Impact of RING and BRCT domain mutations on BRCA1 protein stability, localization and recruitment to DNA damage.","volume":"174","author":"Nelson","year":"2010","journal-title":"Radiat. Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.18632\/aging.101487","article-title":"Fanconi Anemia complementation group C protein in metabolic disorders.","volume":"10","author":"Nepal","year":"2018","journal-title":"Aging (Albany N. Y.)"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18091886","article-title":"The role of PALB2 in the DNA damage response and cancer predisposition.","volume":"18","author":"Nepomuceno","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nrg.2017.47","article-title":"Synthetic lethality and cancer.","volume":"18","author":"O\u2019Neil","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"B87","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/bcr310","article-title":"BRCA2 and homologous recombination.","volume":"3","author":"Orelli","year":"2001","journal-title":"Breast Cancer Res."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1093\/hmg\/dds115","article-title":"Predominance of pathogenic missense variants in the RAD51C gene occurring in breast and ovarian cancer families.","volume":"21","author":"Osorio","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"B89","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2741\/e767","article-title":"BRIP1, a potential candidate gene in development of non-BRCA1\/2 breast cancer.","volume":"8","author":"Ouhtit","year":"2016","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1042\/BST20180418","article-title":"PARPs in genome stability and signal transduction: implications for cancer therapy.","volume":"46","author":"Palazzo","year":"2018","journal-title":"Biochem. Soc. Trans."},{"key":"B91","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bbcan.2014.06.003","article-title":"PALB2: the hub of a network of tumor suppressors involved in DNA damage responses.","volume":"1846","author":"Park","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B92","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1093\/hmg\/ddv251","article-title":"FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor.","volume":"24","author":"Peterlongo","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"B93","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/GIM.0b013e3181d38f2f","article-title":"Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2.","volume":"12","author":"Petrucelli","year":"2010","journal-title":"Genet. Med."},{"key":"B94","first-page":"293","article-title":"The evolution, functions and applications of the breast cancer genes BRCA1 and BRCA2.","volume":"14","author":"Pfeffer","year":"2017","journal-title":"Cancer Genomics Proteomics"},{"key":"B95","doi-asserted-by":"publisher","first-page":"22602","DOI":"10.1074\/jbc.M115.663666","article-title":"FANCD2-associated nuclease 1, but not exonuclease 1 or flap endonuclease 1, is able to unhook DNA interstrand cross-links in vitro.","volume":"290","author":"Pizzolato","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B96","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf9246","article-title":"Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action.","volume":"8","author":"Pommier","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"B97","article-title":"Abstract LB-441: mutation in SLX4 gen in a multiple case breast cancer family.","volume":"72","author":"Ponce","year":"2012","journal-title":"Cancer Res."},{"key":"B98","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/ng1959","article-title":"PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.","volume":"39","author":"Rahman","year":"2007","journal-title":"Nat. Genet."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/jama.2014.5985","article-title":"Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.","volume":"313","author":"Rebbeck","year":"2015","journal-title":"JAMA"},{"key":"B100","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ng1947","article-title":"Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.","volume":"39","author":"Reid","year":"2007","journal-title":"Nat. Genet."},{"key":"B101","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation.","volume":"377","author":"Robson","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B102","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jcp.10257","article-title":"BRCA1 gene in breast cancer.","volume":"196","author":"Rosen","year":"2003","journal-title":"J. Cell. Physiol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/7.10.1555","article-title":"ATM: from gene to function.","volume":"7","author":"Rotman","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"B104","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrc2812","article-title":"PARP inhibition: PARP1 and beyond.","volume":"10","author":"Rouleau","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"B105","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nrc3181","article-title":"BRCA1 and BRCA2: different roles in a common pathway of genome protection.","volume":"12","author":"Roy","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.2353\/ajpath.2010.090779","article-title":"Significance of the Fanconi anemia FANCD2 protein in sporadic and metastatic human breast cancer.","volume":"176","author":"Rudland","year":"2010","journal-title":"Am. J. Pathol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1158\/2159-8290.CD-14-1156","article-title":"Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.","volume":"5","author":"Sawyer","year":"2015","journal-title":"Cancer Discov."},{"key":"B108","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ccr.2012.05.015","article-title":"A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1\/2.","volume":"22","author":"Schlacher","year":"2012","journal-title":"Cancer Cell"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s40265-017-0752-y","article-title":"Niraparib: first global approval.","volume":"77","author":"Scott","year":"2017","journal-title":"Drugs"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/ng1902","article-title":"Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.","volume":"38","author":"Seal","year":"2006","journal-title":"Nat. Genet."},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066961","article-title":"Assessment of SLX4 mutations in hereditary breast cancers.","volume":"8","author":"Shah","year":"2013","journal-title":"PLoS One"},{"key":"B112","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018.","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-017-0024-8","article-title":"The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.","volume":"3","author":"Slavin","year":"2017","journal-title":"NPJ Breast Cancer"},{"key":"B114","doi-asserted-by":"publisher","first-page":"25560","DOI":"10.1074\/jbc.M109.007690","article-title":"The Fanconi anemia protein FANCM is controlled by FANCD2 and the ATR\/ATM pathways.","volume":"284","author":"Sobeck","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2796","article-title":"A PALB2 mutation associated with high risk of breast cancer.","volume":"12","author":"Southey","year":"2010","journal-title":"Breast Cancer Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/ng.751","article-title":"SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype.","volume":"43","author":"Stoepker","year":"2011","journal-title":"Nat. Genet."},{"key":"B117","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng.2007.53","article-title":"The emerging landscape of breast cancer susceptibility.","volume":"40","author":"Stratton","year":"2008","journal-title":"Nat. Genet."},{"key":"B118","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1007\/s13238-011-1098-y","article-title":"The Fanconi anemia pathway and DNA interstrand cross-link repair.","volume":"2","author":"Su","year":"2011","journal-title":"Protein Cell"},{"key":"B119","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/ijc.31105","article-title":"A low-frequency haplotype spanning SLX4\/FANCP constitutes a new risk locus for early-onset breast cancer (<60 years) and is associated with reduced DNA repair capacity.","volume":"142","author":"Surowy","year":"2018","journal-title":"Int. J. Cancer"},{"key":"B120","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.semcdb.2011.07.019","article-title":"RAD51 paralogs: roles in DNA damage signalling, recombinational repair and tumorigenesis.","volume":"22","author":"Suwaki","year":"2011","journal-title":"Semin. Cell Dev. Biol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ejmg.2015.11.013","article-title":"Fanconi anemia with biallelic FANCD1\/BRCA2 mutations \u2013 case report of a family with three affected children.","volume":"59","author":"Svojgr","year":"2016","journal-title":"Eur. J. Med. Genet."},{"key":"B122","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1470-2045(16)30559-9","article-title":"Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.","volume":"18","author":"Swisher","year":"2017","journal-title":"Lancet Oncol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1073\/pnas.0811159106","article-title":"PALB2 is an integral component of the BRCA complex required for homologous recombination repair.","volume":"106","author":"Sy","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B124","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/17460441.2017.1322061","article-title":"Therapeutic targeting and patient selection for cancers with homologous recombination defects.","volume":"12","author":"Talens","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"B125","article-title":"Familial breast cancer.","volume":"37","author":"Thompson","year":"1992","journal-title":"J. R. Coll. Surg. Edinb."},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002894","article-title":"Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles.","volume":"8","author":"Thompson","year":"2012","journal-title":"PLoS Genet."},{"key":"B127","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0140-6736(10)60892-6","article-title":"Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.","volume":"376","author":"Tutt","year":"2010","journal-title":"Lancet"},{"key":"B128","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10549-007-9534-7","article-title":"Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer.","volume":"107","author":"van der Groep","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"B129","first-page":"2585","article-title":"Fanconi anemia gene mutations in young-onset pancreatic cancer.","volume":"63","author":"Van Der Heijden","year":"2003","journal-title":"Cancer Res."},{"key":"B130","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ng.570","article-title":"Mutation of the RAD51C gene in a Fanconi anemia-like disorder.","volume":"42","author":"Vaz","year":"2010","journal-title":"Nat. Genet"},{"key":"B131","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/s0092-8674(02)00615-3","article-title":"Cancer susceptibility and the functions of BRCA1 and BRCA2.","volume":"108","author":"Venkitaraman","year":"2002","journal-title":"Cell"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/s41589-019-0379-2","article-title":"Uncoupling of PARP1 trapping and inhibition using selective PARP1 degradation.","volume":"15","author":"Wang","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"5850","DOI":"10.1128\/mcb.24.13.5850-5862.2004","article-title":"Functional interaction of monoubiquitinated FANCD2 and BRCA2\/FANCD1 in chromatin.","volume":"24","author":"Wang","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1128\/mcb.15.12.6838","article-title":"Checkpoint genes required to delay cell division in response to nocodazole respond to impaired kinetochore function in the yeast Saccharomyces cerevisiae.","volume":"15","author":"Wang","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/CCO.0b013e32835b639e","article-title":"p21WAF1 and tumourigenesis: 20 years after.","volume":"25","author":"Warfel","year":"2013","journal-title":"Curr. Opin. Oncol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1083\/jcb.133.1.75","article-title":"Aberrantly segregating centromeres activate the spindle assembly checkpoint in budding yeast.","volume":"133","author":"Wells","year":"1996","journal-title":"J. Cell Biol."},{"key":"B137","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2.","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"key":"B138","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1126\/science.8091231","article-title":"Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.","volume":"265","author":"Wooster","year":"1994","journal-title":"Science"},{"key":"B139","doi-asserted-by":"publisher","first-page":"10524","DOI":"10.1074\/jbc.TM118.000372","article-title":"Homologous recombination and the repair of DNA double-strand breaks.","volume":"293","author":"Wright","year":"2018","journal-title":"J. Biol. Chem."},{"key":"B140","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/ng1942","article-title":"Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.","volume":"39","author":"Xia","year":"2007","journal-title":"Nat. Genet."},{"key":"B141","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.molcel.2006.05.022","article-title":"Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.","volume":"22","author":"Xia","year":"2006","journal-title":"Mol. Cell"},{"key":"B142","doi-asserted-by":"publisher","first-page":"6492","DOI":"10.1073\/pnas.1018487108","article-title":"Involvement of SLX4 in interstrand cross-link repair is regulated by the Fanconi anemia pathway.","volume":"108","author":"Yamamoto","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B143","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.1349-7006.2004.tb02195.x","article-title":"Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage.","volume":"95","author":"Yoshida","year":"2004","journal-title":"Cancer Sci."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1158\/1541-7786.MCR-09-0123","article-title":"PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2.","volume":"7","author":"Zhang","year":"","journal-title":"Mol. Cancer Res."},{"key":"B145","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cub.2009.02.018","article-title":"PALB2 links BRCA1 and BRCA2 in the DNA-damage response.","volume":"19","author":"Zhang","year":"","journal-title":"Curr. Biol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41586-018-0291-z","article-title":"CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions.","volume":"559","author":"Zimmermann","year":"2018","journal-title":"Nature"},{"key":"B147","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.4161\/15384101.2014.964973","article-title":"BRCA1 and FancJ cooperatively promote interstrand crosslinker induced centrosome amplification through the activation of polo-like kinase 1.","volume":"13","author":"Zou","year":"2014","journal-title":"Cell Cycle"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.00160\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T04:56:39Z","timestamp":1585803399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.00160\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,2]]},"references-count":147,"alternative-id":["10.3389\/fcell.2020.00160"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2020.00160","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,2]]},"article-number":"160"}}